Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
公司代碼NAGE
公司名稱Niagen Bioscience Inc
上市日期Jun 25, 2007
CEOFried (Robert N)
員工數量104
證券類型Ordinary Share
年結日Jun 25
公司地址10900 Wilshire Blvd Suite 600
城市LOS ANGELES
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編90024
電話13103886706
網址https://www.niagenbioscience.com/
公司代碼NAGE
上市日期Jun 25, 2007
CEOFried (Robert N)